RDHL
Redhill Biopharma
$0.42
−$0.01 (−2.57%)Oct 29, 2026
Key metrics
The numbers that frame RDHL today
- Market cap
- $2.12M
- Gross margin
- 57.6%
- ROIC
- 4.1%
- Div yield
- 0%
- 52wk Low
- $0.39
- 52wk High
- $1.60
Growth
Revenue and earnings trend for RDHL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RDHL
Is Redhill Biopharma a good buy?
No. Redhill Biopharma has poor quality and poor momentum. Both signals point to a weaker setup.
What is the market capitalization of RDHL?
Redhill Biopharma's market capitalization is $2.12M.
What is the 52-week high for RDHL stock?
The 52-week high for Redhill Biopharma is $1.60. The current close of $0.42 is 73.9% below that high.
What is the 52-week low for RDHL stock?
The 52-week low for Redhill Biopharma is $0.39. The current close of $0.42 is 6.9% above that low.
Does RDHL stock pay dividends?
Redhill Biopharma does not currently show a dividend per share in the company data.